Symmetry Panoramic Tax-Managed Glb Eq Fd earns a Low Process Pillar rating. The largest detractor from the rating is the parent firm's five-year risk-adjusted success ratio of 38%. The measure ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Nuveen International Equity Fund earns a High Process Pillar rating. The largest contributor to the rating is its parent firm's impressive long-term risk-adjusted performance, as shown by the firm ...

The Al-Quds Brigades – the military wing of the Islamic Jihad Movement – broadcast footage it said showed its fighters firing a barrage of rockets at Israeli occupation forces east of the Netzarim ...

The board of Axis Bank, India’s No.3 lender, on Friday unveiled a two-step operation where it will acquire the equities and investment banking business of Enam Securities and demerge it into a ...

1. Current NAV: The Current Net Asset Value of the Axis Bluechip Fund as of Apr 17, 2025 is Rs 58.28 for Growth option of its Regular plan. 2. Returns: Its trailing returns over different time periods ...

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison. Important Information Please note the value of investments ...